| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 78.43B | 69.08B | 56.86B | 61.95B | 71.62B | 60.74B |
| Gross Profit | 11.74B | 11.10B | 9.80B | 10.50B | 12.05B | 9.77B |
| EBITDA | 3.71B | 3.67B | 3.54B | 3.80B | 4.29B | 3.10B |
| Net Income | 1.48B | 1.38B | 1.01B | 1.61B | 2.03B | 1.21B |
Balance Sheet | ||||||
| Total Assets | 52.63B | 44.23B | 38.75B | 38.92B | 44.51B | 37.99B |
| Cash, Cash Equivalents and Short-Term Investments | 5.33B | 4.76B | 3.57B | 4.32B | 3.96B | 3.13B |
| Total Debt | 5.38B | 5.73B | 3.96B | 4.36B | 5.93B | 4.42B |
| Total Liabilities | 44.66B | 37.57B | 32.67B | 32.87B | 39.12B | 34.38B |
| Stockholders Equity | 7.07B | 6.07B | 5.58B | 5.59B | 4.99B | 3.56B |
Cash Flow | ||||||
| Free Cash Flow | 1.72B | -51.33M | 725.09M | 1.22B | 2.79B | 2.81B |
| Operating Cash Flow | 2.78B | 1.10B | 2.01B | 2.80B | 4.08B | 3.65B |
| Investing Cash Flow | -1.58B | -1.06B | -1.28B | -1.92B | -1.50B | -975.90M |
| Financing Cash Flow | 5.36M | 1.19B | -1.34B | -413.78M | -1.76B | -3.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $83.15B | 8.79 | 64.18% | 0.18% | -16.35% | 316.56% | |
70 Outperform | $97.07B | 13.34 | ― | 1.45% | 10.81% | 31.67% | |
68 Neutral | $14.92B | 6.68 | 23.41% | 4.03% | 19.41% | 36.65% | |
64 Neutral | $19.94B | 14.44 | 112.59% | 1.89% | 2.64% | 4.12% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | $18.75B | 10.90 | 13.19% | ― | 12.22% | -48.34% | |
57 Neutral | $17.80B | 8.26 | ― | 5.09% | 4.09% | -5.77% |